MiniMed Group, Inc. Common Stock (MMED)vs10X Genomics Inc (TXG)
MMED
MiniMed Group, Inc. Common Stock
$16.31
-4.62%
HEALTHCARE · Cap: $4.80B
TXG
10X Genomics Inc
$20.91
+5.55%
HEALTHCARE · Cap: $2.53B
Smart Verdict
WallStSmart Research — data-driven comparison
MiniMed Group, Inc. Common Stock generates 349% more annual revenue ($2.89B vs $642.82M). TXG leads profitability with a -6.8% profit margin vs -7.3%. MMED earns a higher WallStSmart Score of 37/100 (F).
MMED
Hold37
out of 100
Grade: F
TXG
Avoid32
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
No standout strengths identified
Areas to Watch
0.0% earnings growth
ROE of 0.0% — below average capital efficiency
Operating margin of 1.4%
Negative free cash flow — burning cash
0.6% revenue growth
0.0% earnings growth
ROE of -5.8% — below average capital efficiency
Currently unprofitable
Comparative Analysis Report
WallStSmart ResearchBull Case : MMED
Revenue growth of 13.1% demonstrates continued momentum.
Bull Case : TXG
TXG has a balanced fundamental profile.
Bear Case : MMED
The primary concerns for MMED are EPS Growth, Return on Equity, Operating Margin.
Bear Case : TXG
The primary concerns for TXG are Revenue Growth, EPS Growth, Return on Equity.
Key Dynamics to Monitor
MMED is growing revenue faster at 13.1% — sustainability is the question.
TXG generates stronger free cash flow (39M), providing more financial flexibility.
Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
MMED scores higher overall (37/100 vs 32/100) and 13.1% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
MiniMed Group, Inc. Common Stock
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Minimed Group, Inc. is a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company is headquartered in Northridge, California.
10X Genomics Inc
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and Asia Pacific. The company is headquartered in Pleasanton, California.
Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?